Oral papillomatosis in dog
Case report
DOI:
https://doi.org/10.31533/pubvet.v20n1e1889Keywords:
Azithromycin, dogs, oral, papillomaAbstract
Canine oral papillomatosis (COP) is the most common self-limiting neoplastic disease in dogs, caused by the canine oral papillomavirus (COPV). Despite its tendency toward spontaneous regression, treatment of oral papilloma cases is essential due to the physical difficulties animals experience when ingesting food, restrictions on social interaction with other dogs, as well as the occurrence of anorexia, sialorrhea, halitosis, bleeding, secondary bacterial infections, and purulent discharge adjacent to the papillomas. In dogs, azithromycin is used for the treatment of several bacterial conditions and has a favorable safety profile. Based on previous reports and clinical observations, the hypothesis was raised that this drug could be associated with lesion regression in cases of canine oral papillomatosis. In this case report, the clinical course of a dog that underwent surgical removal of the lesions followed by azithromycin administration is described, in which complete regression of the lesions was observed during the follow-up period. The findings are presented as an initial clinical observation, reinforcing the need for controlled studies to evaluate the therapeutic efficacy of azithromycin in canine oral papillomatosis.
References
Agnihotri, D., Kushwah, M., Kumar, T., Kumar, P., Kumar, A., Srikant, & Sindhu, N. (2015). Successful therapeutic management of a case of canine papillomatosis. In Haryana Veterinarian (Vol. 54, pp. 79–80).
Biricik, H., Cabalar, M., & Gulbahar, M. (2008). Papilomatose oral em cão e sua terapia com taurolidina. Acta Veterinária, 77(3), 373–375.
Boehm, T. M. S. A., Bettenay, S., Von Bomhard, W., Majzoub-Altweck, M., Klinger, C. J., & Mueller, R. S. (2021). A case series of canine cutaneous inverted papilloma with one case showing evidence of recurrence. Veterinary Dermatology, 32(3), e268–e274. https://doi.org/10.1111/vde.12961.
Bredal, W. P., Thoresen, S. I., Rimstad, E., Aleksandersen, M., Nafstad, P. H. J., & Agunloye, C. A. (1996). Diagnosis and clinical course of canine oral papillomavirus infection. Journal of Small Animal Practice, 37(3), 138–142. https://doi.org/10.1111/j.1748-5827.1996.tb02364.x.
Campbell, K. L., Sundberg, J. P., Goldschmidt, M. H., Knupp, C., & Reichmann, M. E. (1988). Cutaneous Inverted Papillomas in Dogs. Veterinary Pathology, 25(1). https://doi.org/10.1177/030098588802500109.
Costa, L. A. da, Figueredo, K. R. da S. S., & Kolber, M. (2025). Auto-hemoterapia para o tratamento de papilomatose canina: Relato de caso. Pubvet, 19(01), e1717. https://doi.org/10.31533/pubvet.v19n01e1717.
Dias, F., Pereira, L., Cintra, C., Honsho, C., & Dias, L. G. (2013). Papilomatose oral em cães. Enciclopédia Biosfera, 9(17), 2008–2018.
Feitosa, E. A. L. E. A. L., Bambirra, A. L., Pitanga, M. F., & Feitosa, E. A. L. E. A. L. (2022). Papilomavírus em conjuntiva bulbar da terceira pálpebra em um cão: Relato de caso. PUBVET, 16(7), 1–5. https://doi.org/10.31533/pubvet.v16n07a1155.1-5.
Fernandes, M. C., Ribeiro, M. G., Fedato, F. P., Paes, A. C., & Megid, J. (2009). Papilomatose oral em cães: revisão da literatura e estudo de doze casos. Semina: Ciências Agrárias, 30(1), 215–224. https://doi.org/10.5433/1679-0359.2009v30n1p215.
Ghim, S. J., Newsome, J., Bell, J., Sundberg, J. P., Schlegel, R., & Jenson, A. B. (2000). Spontaneously regressing oral papillomas induce systemic antibodies that neutralize canine oral papillomavirus. Experimental and Molecular Pathology, 68(3), 147–151. https://doi.org/10.1006/exmp.1999.2298.
Gould, A. P., Coyner, K. S., Trimmer, A. M., Tater, K., & Rishniw, M. (2021). Canine pedal papilloma identification and management: a retrospective series of 44 cases. Veterinary Dermatology, 32(5). https://doi.org/10.1111/vde.12999.
Greene, C. E., & Appel, M. J. (2011). Canine distemper. In C. E. Greene (Ed.), Enfermedades infecciosas: Perros y gatos (pp. 25–41). Editora Interamericana.
Hensel, P., Santoro, D., Favrot, C., Hill, P., & Griffin, C. (2015). Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification. BMC Veterinary Research, 11(1), 1–13. https://doi.org/10.1186/s12917-015-0515-5.
Hnilica, K. A., & Patterson, A. P. (2011). Small animal dermatology: a color atlas and therapeutic guide. Elsevier Health Sciences.
Kalita, J., Verma, P., Jakhar, J., & Patidar, S. (2022). Case report on Therapeutic Management of Canine Oral Papillomatosis. International Journal of Pharmaceutical Research and Applications, 7(1).
Kuntsi‐Vaattovaara, H., Verstraete, F. J. M., Newsome, J. T., & Yuan, H. (2003). Resolution of persistent oral papillomatosis in a dog after treatment with a recombinant canine oral papillomavirus vaccine. Veterinary and Comparative Oncology, 1(1), 57–63. https://doi.org/10.1046/j.1476-5829.2003.00005.x.
Lange, C. E., & Favrot, C. (2011). Papilomavírus canino. Veterinary Clinics of North America. Small Animal Practice, 41(6), 1183–1195. https://doi.org/10.1016/j.cvsm.2011.08.003.
Lange, C. E., Jennings, S. H., Diallo, A., & Lyons, J. (2019). Canine papillomavirus types 1 and 2 in classical papillomas: High abundance, different morphological associations and frequent co-infections. The Veterinary Journal, 250, 1–5. https://doi.org/10.1016/j.tvjl.2019.05.016.
Medleau, L., & Hnilica, K. A. (2006). Small animal dermatology. Editora Roca.
Melo, C. B., Jantorno, G. M., Castro, M. B., Lima, E. M. M., & Bastianetto, E. (2025). Canine Oral Papillomatosis - Treatment with Association of Azithromycin and Meloxicam. Acta Scientiae Veterinariae, 53. https://doi.org/10.22456/1679-9216.142719.
Miller, R. L., Gerster, J. F., Owens, M. L., Slade, H. B., & Tomai, M. A. (1999). Review article Imiquimod applied topically: A novel immune response modifier and new class of drug. International Journal of Immunopharmacology, 21(1), 1–14. https://doi.org/10.1016/S0192-0561(98)00068-X.
Miller, W. H., Griffin, C. E., Campbell, K. L., & Muller, G. H. (2013). Muller and Kirk’s Small Animal Dermatology. Elsevier Health Sciences.
Monteiro, V. L. C., & Coelho, M. C. O. C. (2008). Thuja occidentalis e papilomatose. Brazilian Homeopathic Journal, 10(1).
Munday, J. S., Thomson, N. A., & Luff, J. A. (2017). Papillomaviruses in dogs and cats. The Veterinary Journal, 225, 23–31. https://doi.org/10.1016/j.tvjl.2017.04.018.
Nicholls, P. K., Klaunberd, B. A., Moore, R. A., Santos, E. B., Parry, N. R., Gough, G. W., & Stanley. M A. (1999). Natural and Non-Regressive Infection by Canine Oral Papillomavirus: Host Immunity, Virus Characterization, and Experimental Infection. Virology, 265, 265–374. https://doi.org/10.1006/viro.1999.0060.
Queiroz, F. F., Rodrigues, A. B. F., Di Filippo, P. A., Almeida, A. J., & Silveira, L. S. (2015). Thuja occidentalis CH12 as an alternative treatment to dog papilomatosis. Revista Brasileira de Plantas Medicinais, 17, 945–952. https://doi.org/10.1590/1983-084x/14_111.
Raj, P. A. A., Pavulraj, S., Kumar, M. A., Sangeetha, S., Shanmugapriya, R., & Sabithabanu, S. (2020). Therapeutic evaluation of homeopathic treatment for canine oral papillomatosis. Veterinary World, 13(1), 206–213. https://doi.org/10.14202/vetworld.2020.206-213.
Richman, A. W., Kirby, A. L., Rosenkrantz, W., & Muse, R. (2017). Persistent papilloma treated with cryotherapy in three dogs. Veterinary Dermatology, 28(6), 625-e154. https://doi.org/10.1111/vde.12469.
Saibaba, M., Veena, P., Vani, G., Reddy, K. S., & Suresh, K. R. V. (2016). Management of Canine Oral Papillomatosis-A case Report. School Journal Agriculture Veterinay Science, 3(3), 249.
Sancak, A., Favrot, C., Geisseler, M. D., Muller, M., & Lange, C. E. (2015). Os títulos de anticorpos contra o papilomavírus canino tipo 1 atingem o pico próximo à regressão clínica na papilomatose oral de ocorrência natural. Veterinary Dermatology, 26, 57-e20. https://doi.org/10.1111/vde.12189.
Scott, D. W., Miller Junior, W. H., Griffin, C. E., & Figueiredo, C. (1996). Muller & Kirk, dermatologia de pequenos animais. In Muller & Kirk, dermatologia de pequenos animais (pp. xi1130–xi1130). Interlivros.
Sellera, F. P., Nascimento, C. L., & Ribeiro, M. S. (2016). Photodynamic therapy in veterinary medicine: From basics to clinical practice. Springer. https://doi.org/10.1007/978-3-319-45007-0.
Suhett, W. G., Barboza, R. E., Zanette, D. F., Hasuda, A. H., Flaiban, K. K. M. C., Hasuda, A. L., Crespo, S. E. I., Alfiere, A. F., & Bracarense, A. P. F. R. L. (2016). Papilomatose oral canina: Relato de caso. Revista de Ciência Veterinária e Saúde Pública, 3, 198–201.
Sundberg, J. P., Smith, E. K., Herron, A. J., Jenson, A. B., Burk, R. D., & Van Ranst, M. (1994). Involvement of Canine Oral Papillomavirus in Generalized Oral and Cutaneous Verrucosis in a Chinese Shar Pei Dog. Veterinary Pathology, 31(2), 183. https://doi.org/10.1177/030098589403100204.
Thaiwong, T., Sledge, D. G., Wise, A. G., Olstad, K., Maes, R. K., & Kiupel, M. (2018). Malignant transformation of canine oral papillomavirus (CPV1)-associated papillomas in dogs: An emerging concern? Papillomavirus Research, 6, 83–89.
Vieira, L. C., & Poggiani, S. S. C. (2012). Papilomatose canina. PUBVET, 6(16), Art. 1357.
Yaǧci, B. B., Ural, K., Öcal, N., & Haydardedeoǧlu, A. E. (2008). Azithromycin therapy of papillomatosis in dogs: A prospective, randomized, double-blinded, placebo-controlled clinical trial. Veterinary Dermatology, 19(4), 194–198. https://doi.org/10.1111/j.1365-3164.2008.00674.x.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Bruna Warmling, Flávia Coelho de Souza, Ewerton Cardoso, Marcelo Becker, Rafael Silveira, Mateus Rychescki
This work is licensed under a Creative Commons Attribution 4.0 International License.
Você tem o direito de:
Compartilhar — copiar e redistribuir o material em qualquer suporte ou formato
Adaptar — remixar, transformar, e criar a partir do material para qualquer fim, mesmo que comercial.
O licenciante não pode revogar estes direitos desde que você respeite os termos da licença. De acordo com os termos seguintes:
Atribuição
— Você deve dar o crédito apropriado, prover um link para a licença e indicar se mudanças foram feitas. Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso. Sem restrições adicionais
— Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.
